Thierry Lecomte

13.7k citations
292 papers · 10.3k · 2 hit papers · h-index 49

Impact in

  • Oncology top 0.2%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Colorectal Cancer Treatments and Studies 71
    • Pancreatic and Hepatic Oncology Research 37
    • Colorectal Cancer Surgical Treatments 17
    • Gastrointestinal Tumor Research and Treatment 12

Thierry Lecomte

271 papers receiving 10.1k citations

Thierry Lecomte's Hit Papers

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer 2022 · 225 citations
2250+2+5Years since publication5001k1.5k2k

Peers

Thierry Lecomte
Comparison fields: 5 of 121
  • Oncology 5.2k
  • Gastroenterology 666
  • Cancer Research 869
  • Geriatrics and Gerontology 189
  • Pharmacology 495
Replace Hans Prenen with:
Hans Prenen Belgium
Bruno Landi France
Neeltje Steeghs Netherlands
Joel Randolph Hecht United States
Jean‐Baptiste Bachet France
Rosine Guimbaud France
Kazuhiro Yoshida Japan
Halfdan Sørbye Norway
Benjamin R. Tan United States
Thomas Aparicio France
Thierry Lecomte relative to Hans Prenen Belgium Hans Prenen's profile →
Citations per field
00.5×2×3×4.2×
Hans Prenen · 1×
Citations per year

Countries citing papers authored by Thierry Lecomte

Since Specialization
Citations

This map shows the geographic impact of Thierry Lecomte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Lecomte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Lecomte more than expected).

Fields of papers citing papers by Thierry Lecomte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Lecomte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Lecomte. The network helps show where Thierry Lecomte may publish in the future.

Co-authors

The 25 scholars most cited alongside Thierry Lecomte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thierry Lecomte Line = papers co-authored together Thierry Lecomte links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 292 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Hit paper breakdown →
20182184
2 2009570
3 2008303
4 2002250
5
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
Hit paper breakdown →
2022225
6 2014214
7 2004211
8 2006185
9 2013168
10 2018145
11 2015141
12 2016133
13 2012127
14 2010117
15 2005111
16 2016111
17 2003110
18 2011110
19 2021107
20 2015104

About Thierry Lecomte

Thierry Lecomte is a scholar working on Oncology, Gastroenterology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cancer Research, having authored 292 papers that have together received 10.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (71 papers), Pancreatic and Hepatic Oncology Research (37 papers), Gastric Cancer Management and Outcomes (21 papers), Neuroendocrine Tumor Research Advances (20 papers), Genetic factors in colorectal cancer (18 papers), Colorectal Cancer Surgical Treatments (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). The work is most often cited by research in Oncology (5.2k citations), Gastroenterology (666 citations), Cancer Research (869 citations), Geriatrics and Gerontology (189 citations) and Pharmacology (495 citations). Thierry Lecomte has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Pierre Laurent‐Puig, Bruno Landi, Philippe H. Beaune, Olivier Bouché, Thomas Aparicio, Julien Taı̈eb, Paul‐Henri Cugnenc, Anne Berger, Gilles Paintaud and Christophe Cellier. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Digestive and Liver Disease, Journal of Clinical Oncology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact